S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Seven millionaires secretly enable market shock? (Ad)
The Next Stage Of Google’s Rally Just Started
Can Investors Win the Race with Dividend Achiever Nike?
Seven millionaires secretly enable market shock? (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
Seven millionaires secretly enable market shock? (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Seven millionaires secretly enable market shock? (Ad)
The Next Stage Of Google’s Rally Just Started
Can Investors Win the Race with Dividend Achiever Nike?
Seven millionaires secretly enable market shock? (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
Seven millionaires secretly enable market shock? (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Seven millionaires secretly enable market shock? (Ad)
The Next Stage Of Google’s Rally Just Started
Can Investors Win the Race with Dividend Achiever Nike?
Seven millionaires secretly enable market shock? (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
Seven millionaires secretly enable market shock? (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Seven millionaires secretly enable market shock? (Ad)
The Next Stage Of Google’s Rally Just Started
Can Investors Win the Race with Dividend Achiever Nike?
Seven millionaires secretly enable market shock? (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
Seven millionaires secretly enable market shock? (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership

Mesa Laboratories (MLAB) SEC Filings & 10K Form

$105.07
+0.79 (+0.76%)
(As of 09/29/2023 ET)
Compare
Today's Range
$103.25
$106.00
50-Day Range
$104.28
$143.36
52-Week Range
$103.25
$206.36
Volume
37,855 shs
Average Volume
36,457 shs
Market Capitalization
$565.28 million
P/E Ratio
318.40
Dividend Yield
0.61%
Price Target
$166.00

Recent Mesa Laboratories SEC Filings

DateFilerForm TypeView
09/19/2023
11:34 AM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
12:47 PM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:44 PM
Mesa Laboratories (Subject)
Schmieder John Bradley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
11:26 AM
Hall Shannon (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
11:36 AM
Ladiwala Shiraz Shabanali (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
11:15 AM
Alltoft Jennifer Sadie (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
10:59 AM
Mesa Laboratories (Issuer)
Tripeny R Tony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
11:06 AM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
4:11 PM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:34 PM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
11:45 AM
Mesa Laboratories (Subject)
Owens Gary M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2023
2:31 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
1:36 PM
Mesa Laboratories (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/25/2023
3:32 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
2:54 PM
Mesa Laboratories (Issuer)
Tripeny R Tony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
2:45 PM
Ladiwala Shiraz Shabanali (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
2:37 PM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
2:19 PM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
2:28 PM
Alltoft Jennifer Sadie (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
1:03 PM
Hall Shannon (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
7:00 AM
Mesa Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/14/2023
7:00 AM
Mesa Laboratories (Filer)
Form DEF 14A
07/03/2023
9:27 AM
Mesa Laboratories (Filer)
Form PRE 14A
06/26/2023
9:39 AM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
9:45 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
9:29 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
12:38 PM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
12:22 PM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
11:23 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
11:02 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:56 PM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:46 PM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:37 PM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:10 PM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
5:24 PM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
7:01 AM
Mesa Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/25/2023
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2023
8:40 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2023
10:41 AM
Mesa Laboratories (Subject)
Mesa Laboratories (Subject)
Sakys John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2023
8:51 AM
Mesa Laboratories (Subject)
Sakys John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/16/2023
1:42 PM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2023
10:01 AM
Mesa Laboratories (Subject)
Sakys John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2023
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2023
5:13 PM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2023
12:56 PM
Mesa Laboratories (Subject)
Sakys John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2023
7:04 PM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2023
10:50 AM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2023
7:37 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2023
7:00 AM
Mesa Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/02/2023
2:23 PM
Invesco Ltd. (Filed by)
Mesa Laboratories (Subject)
Form SC 13G/A
01/27/2023
10:03 AM
Mesa Laboratories (Subject)
ROYCE & ASSOCIATES LP (Filed by)
Form SC 13G/A
01/25/2023
11:23 AM
Mesa Laboratories (Issuer)
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2023
8:14 AM
Conestoga Capital Advisors, LLC (Filed by)
Mesa Laboratories (Subject)
Form SC 13G/A
01/17/2023
11:33 AM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4/A
01/17/2023
9:52 AM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2023
1:13 PM
Mesa Laboratories (Filer)
Form 8-K/A
12/14/2022
10:26 AM
Ladiwala Shiraz Shabanali (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2022
8:00 AM
Hall Shannon (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2022
9:52 AM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2022
9:06 AM
Mesa Laboratories (Issuer)
Schmieder John Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2022
11:20 AM
Conestoga Capital Advisors, LLC (Filed by)
Mesa Laboratories (Subject)
Form SC 13G/A
11/04/2022
2:50 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2022
1:11 PM
Mesa Laboratories (Filer)
Form 8-K/A
11/03/2022
7:01 AM
Mesa Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2022
7:01 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MLAB) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -